Lorcaserin (APD-356,trade name upon approval Belviq,expected trade name during development,Lorqess is a weight-loss drug developed by Arena Pharmaceuticals.It has serotonergic properties and acts as an anorectic.On 22 December 2009 a New Drug Application (NDA) was submitted to the Food and Drug Administration (FDA) in the United States.On 16 September 2010,an FDA advisory panel voted to recommend against approval of the drug based on concerns over both safety and efficacy.
1.Lorcaserin is used with a doctor-approved exercise,behavior change,and reduced-calorie diet program to help you lose weight.It is used by certain overweight people,such as those who are obese or have weight-related medical problems.Losing weightand keeping it off can lessen the many health risks that come with obesity,comprese le malattie cardiache,diabete,ipertensione,and a shorter life. Lorcaserin belongs to a class of drugs known as serotonin receptor agonists.It is thought to work by affecting a certain part of the brain that helps control your appetite.
2.Lorcaserin is used together with a reduced-calorie diet and proper exercise to help you lose weight.It is also used in overweight people who may also have diabetes,ipertensione,high cholesterol,or heart disease.
Lorcaserin is a prescription medication used to help adults who are obese or who are overweight and have weight-related medical problems to lose weight and keep from gaining back that weight.Lorcaserin must be used along with a reduced calorie diet and an exercise plan.
